Literature DB >> 1682970

Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.

P J Morrison1, D R Hadden, A E Hughes, L Kennedy, C J Russell, N C Nevin.   

Abstract

Gene probe analysis of the MEN 2A locus on chromosome 10 has been undertaken using the markers TB10.163, RBP 3 and TB14.34 in a large kindred with familial medullary thyroid carcinomas, with or without phaeochromocytomas or primary hyperparathyroidism. A maximum LOD score of 2.97 gave strong evidence of close linkage with zero recombination. For 12 members of the family so far not known to be affected by any form of the disease the estimated risk of carrying the gene has been considerably decreased in all but one, whose risk has been greatly increased.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682970

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

1.  Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population.

Authors:  Anna Znaczko; Deirdre E Donnelly; Patrick J Morrison
Journal:  Oncologist       Date:  2014-10-29

2.  The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.

Authors:  Tabib Dabir; Steven J Hunter; Colin F J Russell; Damien McCall; Patrick J Morrison
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 3.  Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome).

Authors:  P J Morrison; N C Nevin
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

4.  Thyroidectomy for medullary carcinoma in MEN 2A: positive genetic screening as the sole indicator for surgery.

Authors:  D McNally; W J Campbell; J M Sloan; P J Morrison; C F Russell
Journal:  Ulster Med J       Date:  1997-11

5.  Disease oriented medicine: the metabolic model.

Authors:  D R Hadden
Journal:  Ulster Med J       Date:  1996-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.